Forecast Link integrates MIDAS historical sales with 10-year forecasts across 10,000 drugs, 600 diseases, 1,200 companies, and 75 countries. Updated quarterly, it projects sales values, volumes, patient days, and implied prices, factoring in launch and loss-of-protection events. The tool supports competitive benchmarking, lifecycle planning, and strategic decisions. Analysts can assess indication-specific forecasts, pipeline growth, and biosimilar erosion risks. Forecast Link delivers comprehensive, reliable, and up-to-date market intelligence to guide long-term product strategies.

Join for free to read